Renk Shares: Record Performance Meets Cautious Guidance

Defense supplier Renk posts record 2025 results but shares dip on conservative 2026 guidance. CFO's insider purchase and analyst upgrades signal confidence in long-term value.

Despite posting historic financial results for the 2025 fiscal year, defense supplier Renk saw its shares come under pressure as investors focused on a more conservative outlook for 2026. This market skepticism was countered, however, by a notable insider purchase from the company's own finance chief.

The company's operational performance was undeniably strong. Revenue climbed by nearly 20% to reach €1.37 billion, while net profit almost doubled to €101.3 million, significantly surpassing prior-year figures. Furthermore, Renk's order backlog swelled to an all-time high of €6.68 billion.

The negative investor reaction stemmed entirely from the forecast for the current year. Management's guidance for adjusted EBIT, targeting a midpoint of approximately €270 million, fell slightly short of analyst consensus expectations. Company executives attributed this primarily to timing issues, noting that orders worth around €200 million had shifted from late 2025 into the first half of 2026. An additional factor cited was the "Israel risk," where €80 to €100 million of projected revenue is contingent upon pending export licenses. This uncertainty has been reflected in the share price, which closed last Friday at €54.54—below the technically significant 50-day moving average of €58.18.

Analyst Support and a Confident Insider Signal

In a move closely watched by the market, CFO Anja Mänz-Siebje acquired company shares on March 9, taking advantage of the lower price level. Such transactions are widely interpreted as a signal that insiders view the current valuation as attractive.

Several equity research firms responded constructively to the company's operational update, issuing revised ratings:
* BNP Paribas upgraded the stock to "Outperform," setting a price target of €65.
* Warburg Research changed its recommendation to "Buy," with a €63 target.
* The consensus price target across 14 covering analysts stands at €68.46.

Looking ahead, investor attention will shift to the upcoming quarterly report and the company's planned 38% dividend increase to €0.58 per share. Renk is scheduled to release its first-quarter 2026 results on May 6. This report will provide the first concrete evidence of whether the delayed orders have successfully translated into revenue and cash flow as management anticipates.